The drug company Moderna has released encouraging data from research on its COVID-19 vaccine candidate. The research has not yet been published in a peer-reviewed medical journal, but it is nonetheless raising hopes. Noubar Afeyan is a co-founder and chairman…

A trial of a U.K.-developed coronavirus vaccine has found that it is safe and induces an immune reaction, according to preliminary results. The research, published in the Lancet medical journal on Monday, shows that a Phase 1/2 trial of more…